GlassScriptPhysician profile
James D Phillips
NPI 1346625944
$22,295.59
in general payments reported to CMS, 2019-2025
28 companies · $2,994 in 2025
The $2,994 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,828 · 2020: $3,456 · 2021: $7,657 · 2022: $5,187 · 2023: $200 · 2024: $974 · 2025: $2,994.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,756 · Travel and Lodging: $228 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $116 · Education: $67.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,756.30 |
| Travel and Lodging | $227.82 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $116.46 |
| Education | $67.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,936.36 | 2021-2024 | |
| Zimmer Biomet Holdings, INC. | $4,578.46 | 2019-2025 | Oxford, Affixus, Juggerknotless Soft Anchor |
| Smith+Nephew, INC. | $4,360.62 | 2020-2025 | Evos, Imhs, Evos Mini |
| Reel Surgical, INC. | $1,596.63 | 2022-2024 | |
| Cgg Medical INC | $1,573.70 | 2021-2025 | |
| Stryker Corporation | $1,264.60 | 2019-2025 | Inspace, Alphavent, Mako |
| Mvp Orthopedics INC | $1,253.16 | 2021 | |
| Medical Device Business Services, INC. | $619.60 | 2019 | |
| Lifenet Health | $119.99 | 2025 | Pliafx Flo |
| Bioventus LLC | $119.31 | 2022-2025 | Durolane |
| Paratek Pharmaceuticals, INC. | $113.30 | 2022-2023 | Nuzyra |
| Biocomposites INC | $102.42 | 2019 | |
| Depuy Synthes Sales INC. | $99.24 | 2019-2025 | Na, Vivigen Mis Delivery System, Lcp |
| Pacira Pharmaceuticals Incorporated | $73.94 | 2022-2024 | Iovera, Exparel, Zilretta |
| Boston Scientific Corporation | $70.54 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maxx Health INC | $67.28 | 2025 | Summa Ortho Distal Radius 2 |
| Linvatec Corporation | $61.18 | 2021-2024 | Biobrace 23mm |
| Calliditas Therapeutics US INC. | $43.48 | 2023-2024 | Tarpeyo |
| Merck Sharp & Dohme LLC | $42.88 | 2024 | Dificid, Recarbrio, Zerbaxa |
| Astrazeneca Pharmaceuticals LP | $39.72 | 2022-2023 | |
| Eisai INC. | $23.38 | 2025 | |
| Genentech USA, INC. | $22.10 | 2024 | Ocrevus |
| Solventum Corporation | $20.21 | 2025 | Prevena, Activ.A.C., 3m Cavilon |
| Janssen Pharmaceuticals, INC | $19.66 | 2022 | |
| Neuros Medical, INC. | $19.55 | 2025 | Altius |
| Ethicon US, LLC | $19.43 | 2024 | Stratafix, Dermabond |
| Seqirus USA INC | $17.99 | 2025 | Flucelvax, Fluad |
| Innovation Technologies INC | $16.86 | 2025 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.